ABSTRACT
Glutathione S-Transferase enzymes (GSTs) constitute the principal Phase II superfamily which plays a key role in cellular detoxification and in other biological processes. Studies of GSTs have revealed that genetic polymorphisms are present in these enzymes and that some of these are Loss-of-Function (LoF) variants, which affect enzymatic functions and are related to different aspects of human health. The aim of this study was to analyze functional genetic differences in GST enzymes among human populations. Attention was focused on LoF polymorphisms of GSTA1, GSTM1, GSTO1, GSTO2, GSTP1 and GSTT1 genes. These LoF variants were analyzed in 668 individuals belonging to six human groups with different ethnic backgrounds: Amhara and Oromo from Ethiopia; Colorado and Cayapa Amerindians and African Ecuadorians from Ecuador; and one sample from central Italy. The HapMap database was used to compare our data with reference populations and to analyze the haplotype and Linkage Disequilibrium diversity in different ethnic groups. Our results highlighted that ethnicity strongly affects the genetic variability of GST enzymes. In particular, GST haplotypes/variants with functional impact showed significant differences in human populations, according to their ethnic background. These data underline that human populations have different structures in detoxification genes, suggesting that these ethnic differences influence disease risk or response to drugs and therefore have implications for genetic association studies involving GST enzymes. In conclusion, our investigation provides data about the distribution of important LoF variants in GST genes in human populations. This information may be useful for designing and interpreting genetic association studies.
Subject(s)
Ethnicity/genetics , Genetic Variation , Glutathione Transferase/genetics , Alleles , Gene Frequency , Genetics, Population , Genotype , Glutathione Transferase/metabolism , HumansABSTRACT
In HSCT setting, KIR-driven alloreactivity might be better predicted if the donor KIR genotype is considered in addition to the recipient HLA genotype. The prediction of NK cell alloreactivity relies on the missing ligand in the recipient, a scenario that can be found in HLA-identical and non-identical allotransplants. The aim of this study was to investigate at genetic level the prognostic impact of recipient HLA-I lacking for donor KIR on allotransplanted patients outcome. We analysed donors KIR genotype and HLA genotype of 60 paediatric patients who received related (n=15) or unrelated (n=45) transplantation. When patients were grouped based on the KIR gene type involved in the KIR/HLA-I mismatch, we did not observe any relapse in the group of patients characterized by mismatches involving only inhibitory KIR. On the contrary, all relapses were observed in patients showing at least one activating gene involved in the mismatch (p<0.05). Although the biological mechanism accounting for this putative genetic rule is still to be clarified, we suggest that a careful survey of KIR/HLA-I mismatching should be taken into account in the selection of donor in related and unrelated HSCT.
Subject(s)
HLA-A1 Antigen/genetics , Hematologic Neoplasms/surgery , Hematopoietic Stem Cell Transplantation/methods , Receptors, KIR/genetics , Adolescent , Child , Child, Preschool , Cohort Studies , DNA Mismatch Repair/genetics , Disease-Free Survival , Female , Follow-Up Studies , Genotype , Graft Rejection/genetics , HLA-A1 Antigen/analysis , Haploidy , Hematologic Neoplasms/mortality , Hematologic Neoplasms/pathology , Hematopoietic Stem Cell Transplantation/adverse effects , Histocompatibility/genetics , Humans , Male , Proportional Hazards Models , Receptors, KIR/analysis , Recurrence , Risk Assessment , Statistics, Nonparametric , Survival Rate , Transplantation, Homologous , Treatment OutcomeABSTRACT
BACKGROUND: Circulating progenitor cells (PCs) may play a role in the pathogenesis of cardiac allograft vasculopathy, the leading cause of morbidity and mortality in heart transplantation (HTx). We assessed the relationship between circulating PCs and their incorporation into allografts and coronary microvascular function in HTx. METHODS: PCs were quantified by flow cytometry on the basis of the surface expression of CD34, CD133, and kinase domain receptor (KDR) antigens. Biopsy specimens at 2 different times were examined. Immunohistochemistry for the stem cell marker c-Kit, endothelial PC (EPC) marker KDR, and CD34 was performed in serial sections in all specimens. Cells positive for each marker were counted in all specimen area sections, and the number obtained was corrected by area section. Coronary flow in the left anterior descending coronary artery was detected at rest and during intravenous adenosine by transthoracic echocardiography. Coronary flow reserve (CFR) was the ratio of hyperemic diastolic mean velocity (DMV)/resting DMV. RESULTS: CFR was measured in 29 patients and was abnormal (CFR < 2) in 6 (Group A) and normal in 23 (Group B). CFR was lower in Group A (1.5 ± 0.1 vs 3.3 ± 0.8, p < 0.0001). CD34(+)KDR(+), CD133(+)KDR(+), and CD34(+)CD133(+)KDR(+) cell counts were lower in Group A (p < 0.05). EPCs in biopsy sections tended to be lower in Group A (p = 0.06) and correlated to circulating CD133(+)KDR(+) and CD34(+)CD133(+)KDR(+) (p = 0.003 and p = 0.052, respectively). CONCLUSIONS: EPCs are decreased in the circulation and in the allograft in patients with microvasculopathy. Defective mobilization and engraftment of EPCs may be involved in the pathogenesis of cardiac allograft vasculopathy.
Subject(s)
Cell Movement , Endothelium, Vascular/pathology , Heart Transplantation/adverse effects , Stem Cells/pathology , Vascular Diseases/etiology , AC133 Antigen , Adult , Antigens, CD/metabolism , Antigens, CD34/metabolism , Blood Flow Velocity , Cell Count , Coronary Circulation , Endothelium, Vascular/metabolism , Female , Glycoproteins/metabolism , Heart Transplantation/pathology , Humans , Male , Microcirculation , Middle Aged , Peptides/metabolism , Stem Cells/metabolism , Transplantation, Homologous , Vascular Diseases/physiopathology , Vascular Endothelial Growth Factor Receptor-2/metabolismABSTRACT
PURPOSE: This study aimed to assess vascular endothelial function in patients with ocular hypertension (OHT) or primary open-angle glaucoma (POAG) by measuring: (a) endothelium-dependent flow-mediated vasodilation (FMD) of the brachial artery, and (b) circulating endothelial progenitor cells, which are believed to support the integrity of the vascular endothelium. METHODS: We enrolled 25 patients with OHT, 23 with POAG and 26 control subjects, all of whom were aged < 65 years and had no medical history of cardiovascular disease or cardiovascular risk factors. All subjects underwent a complete ophthalmological examination, biochemistry study, assessment of cardiovascular parameters, brachial artery ultrasound assessment of endothelium-dependent FMD, generic circulating progenitor cell (CPC) and circulating endothelial progenitor cell (EPC) count with the use of flow cytometry. RESULTS: Flow-mediated vasodilation values differed significantly in OHT (4.5 +/- 1.1%; p = 0.021) and POAG (4.0 +/- 0.9%; p = 0.003) patients compared with controls (7.7 +/- 0.8%). The CD34(+) KDR(+) EPC count was markedly lower in OHT (28.0 +/- 5.0; p < 0.001) and POAG (24.3 +/- 3.4; p < 0.001) patients compared with controls (73.1 +/- 8.1). Neither FMD not EPCs differed significantly between OHT and POAG patients. No significant differences in CPC count or cardiovascular parameters were found among OHT or POAG patients and controls. The levels of CD34(+) KDR(+) EPCs were directly correlated (p = 0.043) with FMD, and inversely correlated (p = 0.032) with baseline intraocular pressure in OHT and POAG patients. CONCLUSIONS: Both OHT and POAG patients without cardiovascular risk factors have previously unreported severely reduced circulating EPCs and reduced FMD, both of which are indicators of endothelial dysfunction and increased risk of cardiovascular events.
Subject(s)
Brachial Artery/physiopathology , Endothelium, Vascular/pathology , Endothelium, Vascular/physiopathology , Glaucoma, Open-Angle/physiopathology , Ocular Hypertension/physiopathology , Stem Cells/pathology , Vasodilation , Adult , Cell Count , Female , Glaucoma, Open-Angle/pathology , Humans , Male , Middle Aged , Ocular Hypertension/pathology , Regional Blood FlowABSTRACT
OBJECTIVE: Our purpose was to study in vitro whether phenotypically-distinct interstitial cell clones from bovine aortic valve (BVIC) possess different calcifying potential in response to endotoxin (lipopolysaccharide [LPS]) and phosphate (Pi). METHODS AND RESULTS: Among various clones of BVIC obtained by limited dilution technique we selected 4 clones displaying different growth patterns and immunophenotypes. Uncloned and cloned cells were treated with combinations of LPS (100 ng/mL) and Pi (2.4 mmol/L). Uncloned BVIC showed increased alkaline phosphatase activity (ALP) after treatment with LPS, which resulted in calcification after addition of Pi. Among BVIC clones, only Clone 1 (fibroblast-like phenotype) showed a relevant increase in ALP after LPS treatment in parallel with prevention of smooth muscle (SM) alpha-actin accumulation. No effect was observed in clonal cells harboring a more stable SM cell-like profile (Clone 4). None of the isolated clones calcified but mineralization was induced in the presence of LPS plus Pi when Clone 1 was cocultured with Clone 4 or after seeding on type I collagen sponges. CONCLUSIONS: Endotoxin and phosphate can act as valve calcification promoters by targeting specific fibroblast-like interstitial valve cells that possess a unique procalcific potential.
Subject(s)
Aortic Valve/drug effects , Aortic Valve/pathology , Calcinosis/etiology , Heart Valve Diseases/etiology , Lipopolysaccharides/toxicity , Phosphates/toxicity , Alkaline Phosphatase/metabolism , Animals , Aortic Valve/metabolism , Calcinosis/metabolism , Calcinosis/pathology , Calcium/metabolism , Cattle , Clone Cells , Coculture Techniques , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibroblasts/pathology , Heart Valve Diseases/metabolism , Heart Valve Diseases/pathology , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/metabolism , Myocytes, Smooth Muscle/pathology , PhenotypeABSTRACT
OBJECTIVE: The loss of myenteric neurons in the lower esophageal sphincter (LES) characterizes achalasia, an esophageal motor disorder. Because the presence of lymphocytic infiltrates suggests an immuno-mediated mechanism ongoing at the sites of disease, we investigated the T-cell receptor (TCR) repertoire and the ability to recognize human herpes virus type 1 (HSV-1) antigens of LES-infiltrating T lymphocytes in achalasia patients. METHODS: Fifty-nine patients with idiopathic achalasia and 38 heart-beating cadaveric multiorgan donors (controls) were studied. By flow cytometry evaluation and CDR3 length spectratyping analysis, the lymphocytes of 18 patients and 15 controls were analyzed, whereas 41 patients and 23 controls were employed for functional assays. RESULTS: Achalasia patients were characterized by a significantly higher esophagus lymphocytic infiltrate than controls (24.71%+/- 3.11 and 9.54%+/- 1.34, respectively; P < 0.05), mainly represented by CD3+CD8+ T cells. The characterization of TCR beta chain repertoire of CD3+ cells showed the expression of a limited number of TCR beta variable (BV) gene families (from two to five out of 26), with highly restricted spectratypes, suggesting a disease-associated oligoclonal selection of T cells. Furthermore, lymphocytes from achalasia LES specifically responded to exposure to HSV-1 antigens in vitro as showed by increased proliferation and Th-1 type cytokines release. CONCLUSIONS: These data suggest that the oligoclonal lymphocytic infiltrate within the LES of achalasia patients may represent the trace of an immune-inflammatory reaction triggered by HSV-1 antigens and that the Th1-type cytokines released by the activated lymphocytes may contribute to establish the neuronal damage accounting for the clinical features of idiopathic achalasia.
Subject(s)
Antigens, Viral/immunology , Esophageal Achalasia/immunology , Herpesvirus 1, Human/immunology , Myenteric Plexus/immunology , Receptors, Antigen, T-Cell/analysis , T-Lymphocytes/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Cadaver , Esophageal Sphincter, Lower/innervation , Female , Flow Cytometry , Humans , Male , Middle Aged , Polymerase Chain ReactionABSTRACT
OBJECTIVE: Endothelial progenitor cells (EPCs) participate in vascular homeostasis and angiogenesis. The aim of the present study was to explore EPC number and function in relation to cardiovascular risk, gender, and reproductive state. METHODS AND RESULTS: As measured by flow-cytometry in 210 healthy subjects, CD34(+)KDR(+) EPCs were higher in fertile women than in men, but were not different between postmenopausal women and age-matched men. These gender gradients mirrored differences in cardiovascular profile, carotid intima-media thickness, and brachial artery flow-mediated dilation. Moreover, EPCs and soluble c-kit ligand varied in phase with menstrual cycle in ovulatory women, suggesting cyclic bone marrow mobilization. Experimentally, hysterectomy in rats was followed by an increase in circulating EPCs. EPCs cultured from female healthy donors were more clonogenic and adherent than male EPCs. Treatment with 17beta-estradiol stimulated EPC proliferation and adhesion, via estrogen receptors. Finally, we show that the proangiogenic potential of female EPCs was higher than that of male EPCs in vivo. CONCLUSIONS: EPCs are mobilized cyclically in fertile women, likely to provide a pool of cells for endometrial homeostasis. The resulting higher EPC levels in women than in men reflect the cardiovascular profile and could represent one mechanism of protection in the fertile female population.
Subject(s)
Cardiovascular Diseases/etiology , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Estrogens/metabolism , Mesenchymal Stem Cells/metabolism , Mesenchymal Stem Cells/pathology , Sex Characteristics , Adult , Aged , Animals , Ataxin-1 , Ataxins , Cardiovascular Diseases/metabolism , Cardiovascular Diseases/pathology , Cell Adhesion/physiology , Cell Proliferation/drug effects , Cells, Cultured , Estradiol/pharmacology , Female , Homeostasis/physiology , Humans , Infant, Newborn , Male , Menstrual Cycle/metabolism , Middle Aged , Neovascularization, Physiologic/physiology , Nerve Tissue Proteins/metabolism , Nuclear Proteins/metabolism , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Proto-Oncogene Proteins c-kit/metabolism , Rats , Receptors, Estrogen/metabolism , Risk FactorsABSTRACT
In the last 10 years an increasing interest has been devoted to the study of endothelial progenitor cells (EPCs), a subtype of immature cells involved in endothelial repair and neoangiogenesis. EPCs have been discovered as a novel integrated part of the cardiovascular system, which plays a comprehensive role in tissue homeostasis. Consistently, alterations and/or reduction of the circulating EPC pool have been associated with different manifestations of cardiovascular disorders and atherosclerosis. This is why, the extent of the EPC pool is now considered a mirror of vascular health, while EPC reduction has become a surrogate biomarker of cardiovascular risk and of the ongoing vascular damage. Unfortunately, the methods used to study EPCs still lack standardization, and this is significantly decelerating progress in the field. In this review, we focus on some aspects related to the two methods used to assess circulating EPCs: flow cytometry and cell culture. We uncover the many traps hidden in the choice of the right protocol, and suggest the best solutions on the basis of evidence and background theories.
Subject(s)
Antigens, CD/classification , Endothelial Cells/cytology , Stem Cells/cytology , Atherosclerosis/physiopathology , Biomarkers/blood , Cell Culture Techniques , Endothelial Cells/physiology , Flow Cytometry/methods , Humans , Neovascularization, Physiologic/physiology , Reagent Kits, Diagnostic , Stem Cells/physiologySubject(s)
Diabetes, Gestational/drug therapy , Endothelium, Vascular/embryology , Fetus/physiology , Insulin/therapeutic use , Pregnancy in Diabetics/drug therapy , Stem Cells/cytology , Birth Weight/drug effects , Endothelium, Vascular/drug effects , Endothelium, Vascular/physiology , Female , Fetal Blood/cytology , Fetal Blood/drug effects , Fetus/drug effects , Glycated Hemoglobin/metabolism , Humans , Hyperglycemia/prevention & control , Hypoglycemic Agents/therapeutic use , Infant, Newborn , Pregnancy , Stem Cells/drug effectsABSTRACT
Chemokines and their receptors play a pivotal role in the regulation of B-lymphocyte trafficking. This study was aimed at investigating the pattern of chemokine receptor expression, including CCR1 to CCR3, CCR5 to CCR7, CXCR1 to CXCR5, and the migration ability of multiple myeloma (MM) plasma cells (PC). PC were recovered from the bone marrow (BM) of 29 MM patients, extramedullary sites of 10 patients and the BM of five controls. Flow cytometry analysis showed that the receptors mainly expressed on malignant BM PC were represented by CXCR4 (70% of patients), CCR1 (25%), CCR2 (25%), CCR5 (17%) and CXCR3 (20%), while other receptors were commonly lacking. The analysis performed on extramedullary (peripheral blood and pleural effusion) malignant PC demonstrated that the most represented receptors were CXCR4 (100%), CCR2 (66%) and CXCR1 (60%). The migratory capability of malignant PC at resting conditions identified three groups of patients with different migration (low, intermediate and high). As CXCR4 was the relevant chemokine receptor expressed by MM PC, its ligand CXCL12 induced their migration. These data suggest that malignant PC from MM display different chemokine receptor profiles and that CXCR4 is fully functional and might play a role in the spreading of the disease.
Subject(s)
Multiple Myeloma/immunology , Plasma Cells/immunology , Receptors, Chemokine/metabolism , Adult , Aged , Aged, 80 and over , Bone Marrow Cells/immunology , Chemokine CXCL12 , Chemokines, CXC/metabolism , Chemotaxis, Leukocyte/immunology , Female , Flow Cytometry , Humans , Male , Middle Aged , Pleural Effusion/immunology , Receptors, CCR2 , Receptors, CXCR4/metabolism , Receptors, Interleukin-8A/metabolism , Tumor Cells, CulturedABSTRACT
We have shown previously that the chemokine receptors CXCR3 and CXCR6 are coexpressed by Th1 cells infiltrating the lung and the granuloma of patients with sarcoidosis. In this study, we evaluated the role of CCL20/CCR6 interaction in the pathogenesis of acute and chronic pulmonary sarcoidosis. By flow cytometry and molecular analyses, we have demonstrated that Th1 cells isolated from the bronchoalveolar lavage (BAL) of patients with sarcoidosis and T cell alveolitis are equipped with CCR6. Furthermore, CCR6(+) T cells coexpressed the chemokine receptors CXCR3 and CXCR6. Immunohistochemical analysis of lung specimens has shown that CCR6(+) T cells infiltrate lung interstitium and surround the central core of the granuloma. It is interesting that CCR6 was never detected on the alveolar macrophage (AM) surface, and it is observed in the cytoplasm of AMs from patients with sarcoidosis and alveolitis. The CCR6 ligand CCL20 was expressed by macrophages, multinucleated giant cells, and epithelioid cells infiltrating the granuloma. Furthermore, detectable levels of CCL20 protein are seen in the BAL fluid components of patients with active sarcoidosis, and sarcoid AMs release the CCR6 ligand in vitro. From a functional point of view, sarcoid Th1 cells were able to respond to CXCL10, CXCL16, and CCL20 in migratory assays. In vitro kinetic studies demonstrated that CCR6 is induced rapidly by IL-2, IL-18, and IFN-gamma. In conclusion, T cells expressing CCR6, CXCR3, and CXCR6 act coordinately with respective ligands and Th1 inflammatory cytokines in the alveolitic/granuloma phases of the disease.
Subject(s)
Chemokine CCL20/immunology , Gene Expression Regulation/immunology , Lung/immunology , Macrophage Inflammatory Proteins/immunology , Receptors, CCR6/immunology , Sarcoidosis, Pulmonary/immunology , Acute Disease , Adult , Bronchoalveolar Lavage , Cells, Cultured , Chemokine CCL20/biosynthesis , Chemokine CXCL10/biosynthesis , Chemokine CXCL10/immunology , Chemokine CXCL16 , Chemokines, CXC/biosynthesis , Chemokines, CXC/immunology , Chronic Disease , Epithelioid Cells/immunology , Epithelioid Cells/metabolism , Epithelioid Cells/pathology , Female , Gene Expression Regulation/drug effects , Giant Cells/immunology , Giant Cells/metabolism , Giant Cells/pathology , Granuloma, Respiratory Tract/immunology , Granuloma, Respiratory Tract/metabolism , Granuloma, Respiratory Tract/pathology , Humans , Interferon-gamma/immunology , Interferon-gamma/pharmacology , Interleukin-18/immunology , Interleukin-18/pharmacology , Interleukin-2/immunology , Interleukin-2/pharmacology , Lung/metabolism , Lung/pathology , Macrophage Inflammatory Proteins/biosynthesis , Macrophages, Alveolar/immunology , Macrophages, Alveolar/metabolism , Macrophages, Alveolar/pathology , Male , Middle Aged , Receptors, CCR6/biosynthesis , Receptors, CXCR3 , Receptors, CXCR6 , Receptors, Chemokine/biosynthesis , Receptors, Chemokine/immunology , Receptors, Scavenger/biosynthesis , Receptors, Scavenger/immunology , Receptors, Virus/biosynthesis , Receptors, Virus/immunology , Sarcoidosis, Pulmonary/metabolism , Sarcoidosis, Pulmonary/pathology , Th1 Cells/immunology , Th1 Cells/metabolismABSTRACT
By analyzing the expression of several cytotoxic markers, killer-immunoglobulin-like receptors (KIRs), CD94/CD159, CD314 and natural cytotoxicity receptors (NCRs), in 22 CD3+ lymphoproliferative disease of granular lymphocyte (LDGL) patients we investigated whether granular lymphocytes (GLs) displayed the phenotype of fully differentiated cytotoxic cells. Our results demonstrate that GLs express a pattern consistent with fully differentiated CTLs. KIRs are expressed only in a fraction of patients (7/22), as is CD94/CD159 (5/22). In conclusion, GLs in CD3+ LDGL patients typically show the phenotype of fully differentiated CTL, whereas the expression of NK receptors does not represent a common feature of the proliferating clone.
Subject(s)
Lymphocytes/immunology , Lymphoproliferative Disorders/immunology , T-Lymphocytes, Cytotoxic/immunology , Aged , CD3 Complex/immunology , Cell Differentiation/immunology , Female , Humans , Immunophenotyping , Male , NK Cell Lectin-Like Receptor Subfamily K , Receptors, IgG/immunology , Receptors, Immunologic/biosynthesis , Receptors, Immunologic/immunology , Receptors, KIR , Receptors, Natural Killer CellABSTRACT
AIMS: Circulating progenitor cells are believed to participate in cardiovascular (CV) homeostasis and their exhaustion has been linked to CV damage. As general agreement on their characterization is lacking, this work was carried out to assess the relationships between different antigenic profiles of progenitor cells and CV risk, with special regard to metabolic syndrome (MetSyn). METHODS AND RESULTS: CD34, CD133, and KDR were used to quantify circulating progenitors in 214 subjects at different levels of CV risk. In a cross-analysis of six different cell subtypes (CD34(+), CD133(+), CD34(+)CD133(+), CD34(+)KDR(+), CD133(+)KDR(+), and CD34(+)CD133(+)KDR(+)), CD34(+) progenitors showed the best correlation with CV parameters and risk estimates. Components of the MetSyn were all characterized by reduction of CD34(+) cells and acted synergistically in decreasing CD34(+) cell count. Moreover, CD34(+) cell count demonstrated a high performance in detecting high CV risk. CONCLUSION: These data demonstrate that CD34 identifies progenitor cells linked to CV risk, showing a close negative correlation between CD34(+) cells and CV risk, as well as a synergic detrimental effect of clustered metabolic components. Progenitor cell count may be used as a surrogate marker of CV risk, whereas extensive antigenic characterization may not be useful for this purpose.
Subject(s)
Antigens, CD34 , Cardiovascular Diseases/pathology , Endothelium, Vascular/pathology , Metabolic Syndrome/pathology , Stem Cells/pathology , Female , Humans , Male , Middle Aged , Regression Analysis , Risk FactorsABSTRACT
BACKGROUND AND PURPOSE: Disruption of the endothelial layer is the first step in the atherogenic process. Experimental studies have shown that endothelial progenitor cells (EPCs) are involved in endothelial homeostasis and repair. Conversely, EPC depletion has been demonstrated in the setting of established atherosclerotic diseases. With this background, we evaluated whether variations in the number of EPCs are associated with subclinical atherosclerosis in healthy subjects. METHODS: Carotid intima-media thickness (IMT), high-sensitive C-reactive protein (hsCRP), levels of circulating EPCs, and cardiovascular risk were compared in 137 healthy subjects. Six subpopulations of progenitor cells were determined by flow cytometry on the basis of the surface expression of CD34, CD133, and KDR antigens: CD34(+), CD133(+), CD34(+)CD133(+), CD34(+)KDR(+), CD133(+)KDR(+), and CD34(+)CD133(+)KDR(+). RESULTS: Among different antigenic profiles of EPCs, only CD34(+)KDR(+) cells were significantly reduced in subjects with increased IMT. Specifically, CD34(+)KDR(+) cells were inversely correlated with IMT, even after adjustment for hsCRP and 10-year Framingham risk and independently of other cardiovascular parameters. CONCLUSIONS: Depletion of CD34(+)KDR(+) EPCs is an independent predictor of early subclinical atherosclerosis in healthy subjects and may provide additional information beyond classic risk factors and inflammatory markers.
Subject(s)
Antigens, CD34/metabolism , Antigens, Surface/metabolism , Blood Cells/metabolism , Endothelial Cells/metabolism , Intracranial Arteriosclerosis/blood , Intracranial Arteriosclerosis/diagnostic imaging , Stem Cells/metabolism , Adult , Carotid Arteries/diagnostic imaging , Cell Count , Endothelial Cells/pathology , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Stem Cells/pathology , Tunica Intima/diagnostic imaging , Tunica Media/diagnostic imaging , UltrasonographyABSTRACT
OBJECTIVE: Peripheral arterial disease (PAD) is a threatening complication of diabetes. As endothelial progenitor cells (EPCs) are involved in neovasculogenesis and maintenance of vascular homeostasis, their impairment may have a role in the pathogenesis of diabetic vasculopathy. This study aimed to establish whether number and function of EPCs correlate with PAD severity in type 2 diabetic patients. METHODS AND RESULTS: EPCs were defined by the expression of CD34, CD133 and KDR, and quantified by flow cytometry in 127 diabetic patients with and without PAD. PAD severity has been assessed as carotid atherosclerosis and clinical stage of leg atherosclerosis obliterans. Diabetic patients with PAD displayed a significant 53% reduction in circulating EPCs versus non-PAD patients, and EPC levels were negatively correlated with the degree of carotid stenosis and the stage of leg claudication. Moreover, the clonogenic and adhesion capacity of cultured EPCs were significantly lower in diabetic patients with PAD versus patients without. CONCLUSIONS: This study demonstrates that EPC decrease is related to PAD severity and that EPC function is altered in diabetic subjects with PAD, strengthening the pathogenetic role of EPC dysregulation in diabetic vasculopathy. EPC count may be considered a novel biological marker of peripheral atherosclerosis in diabetes.
Subject(s)
Diabetic Angiopathies/pathology , Diabetic Angiopathies/physiopathology , Endothelial Cells/pathology , Peripheral Vascular Diseases/pathology , Peripheral Vascular Diseases/physiopathology , Stem Cells/pathology , Aged , Arteries , Blood Cells/pathology , Carotid Stenosis/pathology , Carotid Stenosis/physiopathology , Case-Control Studies , Cell Adhesion , Cell Count , Cells, Cultured , Colony-Forming Units Assay , Diabetes Mellitus, Type 2 , Female , Flow Cytometry , Humans , Intermittent Claudication/pathology , Intermittent Claudication/physiopathology , Leg/blood supply , Male , Severity of Illness IndexABSTRACT
Patients with chronic severe lung disease are prone to develop pulmonary vascular remodeling, possibly through pulmonary endothelial dysfunction. Circulating endothelial progenitor cells (EPCs) are involved in maintenance of endothelial homeostasis. The aim of this study was to assess whether obstructive and restrictive lung diseases are associated with modification of EPC number in peripheral blood. The study was cross-sectional and involved patients with obstructive (n = 15) and restrictive (n = 15) lung disease on oxygen therapy and 15 control subjects. Circulating EPCs were defined by the surface expression of CD34, CD133, and kinase-insert domain receptor. Results from spirometric tests, blood gas analyses, and blood cell counts have been related to EPC numbers. Patients with chronic hypoxia and severe lung disease showed lower levels of all progenitors than do control subjects. A consensual further reduction of EPC was found in restrictive patients in comparison with obstructive patients. Among restrictive patients, EPC reduction was related to reduced lung volumes and impaired alveolo-arterial diffusion, whereas progenitor cell levels were directly related to erythrocyte number. Considering obstructive patients, significant correlations were found between progenitor cell levels and bronchial obstruction and between progenitor cell levels and arterial oxygen tension. These findings demonstrate a reduction of EPCs in patients with chronic lung disease and long-lasting hypoxia. This alteration was more evident in restrictive patients and correlated to disease severity. Depletion of circulating EPCs may be involved in altered endothelial homeostasis of pulmonary circulation in these disorders.
Subject(s)
Endothelium, Vascular/pathology , Lung Diseases/blood , Lung Diseases/pathology , Stem Cells/pathology , Aged , Blood Cell Count , Case-Control Studies , Chronic Disease , Endothelial Cells/pathology , Female , Humans , Hypoxia/blood , Hypoxia/complications , Hypoxia/pathology , Lung Diseases/complications , Lung Diseases, Obstructive/blood , Lung Diseases, Obstructive/pathology , Male , Middle Aged , Smoking/adverse effectsSubject(s)
Diabetes Mellitus, Type 2/physiopathology , Diabetic Retinopathy/pathology , Peripheral Vascular Diseases/pathology , Stem Cells/physiology , Adult , Aged , Antigens, CD34/analysis , Cell Differentiation/physiology , Diabetic Retinopathy/immunology , Diabetic Retinopathy/physiopathology , Endothelial Cells/immunology , Endothelium, Vascular/cytology , Endothelium, Vascular/physiopathology , Humans , Middle Aged , Neovascularization, Pathologic , Peripheral Vascular Diseases/immunology , Peripheral Vascular Diseases/physiopathology , Prospective StudiesABSTRACT
Expression of CXCR3-targeting chemokines have been demonstrated in several diseases, suggesting a critical role for CXCR3 in recruiting activated T cells to sites of immune-mediated inflammation. Sjögren's syndrome (SS) is an autoimmune disease characterized by a mononuclear cell infiltrate of activated T cells around the duct in the salivary gland. Analysis of minor salivary gland biopsy specimens from 20 healthy subjects and 18 patients with primary SS demonstrated that CXCR3, in particular, the B form of this receptor, is constitutively expressed by human salivary gland epithelial cells. Salivary gland epithelial cell cultures demonstrated that CXCR3 participate in removing relevant amount of agonists from the supernatant of exposed cells without mediating calcium flux or chemotaxis while retaining the ability to undergo internalization. Although in normal salivary gland epithelial cells, CXCR3 behaves as a chemokine-scavenging receptor, its role in SS cells is functionally impaired. The impairment of this scavenging function might favor chemotaxis, leading to heightened immigration of CXCR3-positive T lymphocytes. These findings suggest that epithelial CXCR3 may be involved in postsecretion regulation of chemokine bioavailability. They also support a critical role for CXCR3 in the pathogenesis of SS and identify its agonists as potential therapeutic targets.
Subject(s)
Chemokines/metabolism , Epithelial Cells/metabolism , Receptors, Chemokine/metabolism , Salivary Glands/metabolism , Sjogren's Syndrome/metabolism , Adult , Aged , Biological Availability , Cells, Cultured , Chemokine CXCL10 , Chemokines, CXC/metabolism , Chemotaxis , Epithelial Cells/cytology , Female , Humans , Ligands , Middle Aged , Receptors, CXCR3 , Receptors, Chemokine/agonists , Salivary Glands/cytology , Salivary Glands/immunology , Sjogren's Syndrome/immunologyABSTRACT
We investigated whether dendritic cells (DCs) play a role in favoring granular lymphocyte (GL) proliferation in patients with lymphoproliferative disease of granular lymphocytes (LDGL). The presence of in vivo circulating DCs was studied in 11 patients (5 CD3+ and 6 CD3- LDGL). Autologous immature (iDCs) and mature (mDCs) DCs generated in vitro were studied for stimulatory activity on cell proliferation of CD3+ and CD3- GLs. The topographic organization of GLs and DCs was also studied in bone marrow (BM) biopsies. Peripheral blood (PB) CD3- GLs from patients showed significant proliferative activity in the presence of iDCs and mDCs. Conversely, monoclonal CD3+ GLs were unresponsive to autologous and allogeneic PB DCs. Analysis of BM biopsies demonstrated a topographic distribution of DCs and GLs that indicates contact between the 2 cell types. On functional assays, DCs obtained from BM were more efficient than PB DCs in stimulating CD3- GLs, and surprisingly, a low but definite stimulatory effect was demonstrated also on CD3+ GLs. The putative contact between DCs and GLs in the BM and, more crucial, the proliferative response of discrete GL populations to DC stimulation suggest the presence of a specific antigen within BM DCs, providing evidence for a role of DCs in the pathogenesis of LDGL.
Subject(s)
Cell Communication/immunology , Dendritic Cells/metabolism , Granulocytes/metabolism , Lymphoproliferative Disorders/metabolism , CD3 Complex/metabolism , Cell Proliferation , Dendritic Cells/immunology , Flow Cytometry , Granulocytes/immunology , Granulocytes/pathology , Humans , Immunohistochemistry , Immunophenotyping , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Lymphoproliferative Disorders/immunology , T-Lymphocytes/immunology , T-Lymphocytes/metabolismABSTRACT
A role for circulating progenitor cells have been recently demonstrated in many pathological conditions. Endothelial progenitor cells (EPCs) localize at sites of ischemia and stimulate neovasculogenesis. This small study was carried out to assess whether selective blood sampling during renal angiography could demonstrate an arterio-venous gradient of EPCs in 5 patients with renal artery stenosis. Surprisingly, we found that EPCs were more abundant in venous than in arterial blood, suggesting that the kidney subjected to chronic ischemia may become a source rather than a target of EPCs.